marrow purging complement and 4- hydroperoxycyclophosphamide for ex vivo bone monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus B-lineage acute lymphoblastic leukemia using a cocktail of three Autologous bone marrow transplantation in high-risk remission